Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
2 |
|
2013 |
2013 |
Nijmegen Breakage Syndrome
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
94
|
144
|
0.020 |
None |
0.500 |
2 |
|
2010 |
2013 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
112
|
|
0.300 |
None |
1.000 |
2 |
|
2013 |
2013 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2013 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Gram-Positive Bacterial Infections
|
group |
Infections
|
Disease or Syndrome
|
17
|
1
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Xeroderma Pigmentosum, Complementation Group D
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
70
|
111
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
18
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Behcet Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Skin and Connective Tissue Diseases; Stomatognathic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
502
|
243
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Demyelinating Diseases
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
156
|
5
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Bacterial Infections
|
group |
Infections
|
Disease or Syndrome
|
616
|
17
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Mitochondrial Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
284
|
84
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Degeneration of lumbar intervertebral disc
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
50
|
6
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Infarction, Middle Cerebral Artery
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
145
|
|
0.200 |
None |
1.000 |
1 |
|
2013 |
2013 |
Metastatic malignant neoplasm to brain
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
392
|
28
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Optic Atrophy
|
disease |
Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
568
|
51
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Malignant neoplasm of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
699
|
32
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Sarcoma of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
258
|
6
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Gram-positive bacteremia
|
disease |
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Todd Paralysis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
10
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Experimental Autoimmune Encephalomyelitis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Experimental Model of Disease
|
97
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
dowling-degos disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
53
|
7
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
High-Grade Prostatic Intraepithelial Neoplasia
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
111
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Clinically Isolated Syndrome, CNS Demyelinating
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
9
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Paralysed
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
68
|
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |